Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds
- PMID: 26883954
- DOI: 10.1136/bmj.i931
Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds
Comment on
-
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis.Ann Intern Med. 2016 Apr 5;164(7):472-8. doi: 10.7326/M15-1839. Epub 2016 Feb 16. Ann Intern Med. 2016. PMID: 26881842
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical